Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Minimum steroid dose added to incision anesthesia to reduce pain after spine surgery

Official title: Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery: a Randomised Controlled Trial

Run by Beijing Tiantan Hospital · NCT06785350 · Data updated 2026-11-12

This trial tests whether adding different low doses of betamethasone to ropivacaine injected into the incision reduces pain after spine surgery.

More Pain Management trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment535 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 25, 2025
Main results expectedSeptember 1, 2025
Study endsDecember 1, 2025
Registry record updatedJuly 16, 2025
Trial IDNCT06785350 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 years old with ASA physical status I–II scheduled for cervical, thoracic, or lumbar spine surgery of up to three levels who can give informed consent are the intended participants.

Probably not a fit

Patients with prior spinal surgery, peri-incisional infection, diabetes or other metabolic disorders, significant liver or kidney dysfunction, current systemic steroid use, pregnancy or breastfeeding, extreme BMI, serious neurologic or psychiatric disease, or substance abuse are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults aged 18–65 undergoing cervical, thoracic, or lumbar spine surgery (up to three levels) at Beijing Tiantan Hospital will receive local infiltration of the surgical incision with one of five regimens: 0.5% ropivacaine alone or ropivacaine combined with betamethasone (Diprospan) at 0.012%, 0.009%, 0.006%, or 0.003%. The study compares postoperative incisional pain and related outcomes to identify the minimum effective concentration of betamethasone when used with local anesthetic. Standard perioperative care is provided and patients with significant comorbidities or contraindications are excluded. Results aim to guide dosing to minimize pain and opioid requirements after spine surgery.

Why it matters

Potential benefit: If successful, patients could have less incision pain after spine surgery, shorter recovery, and lower opioid use.

How similar studies have gone: Previous reports of local infiltration combining anti-inflammatory drugs with local anesthetic have reduced postoperative pain, but the optimal steroid concentration for spinal incision infiltration remains unestablished.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients scheduled for spine surgery under general anesthesia. Anticipated cervical, thoracic, and lumbar spine surgeries (within three level).

Patients age 18-65 years. American Society of Anaesthesiologists Classification of I or II.

Exclusion Criteria:

Patients refuse to participate. Patients who are allergic to ropivacaine, betamethasone and opioid, . Pateints who have been abusing drugs or alcohol. Patients who have abnormalities in kidney or liver function tests. BMI\<15kg/m2 or\>35 kg/m2. Patient has a history of spinal surgery. Patient has peri-incisional infection. Patient has a history of stroke or other serious neurological disease. Patient has a history of diabetes and other metabolic disorders. Patient has a history of psychological disorders. Patient is on systemic steroids. Patient is pregnant or breastfeeding. Glasgow Coma Scale score \< 15 before surgery. Unable to provide written informed consent.

Withdrawal criteria:

Voluntary withdrawal. Delayed extubation. Poor cognitive function within 48 hours after surgery. Postoperative radiation therapy or chemotherapy during follow-up. Postoperative diagnosis of spinal cord or nerve root injury resulting in pain during follow-up.

Reoperation during follow-up.

Where it's running

  • Beijing Tiantan Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.